Skip to main content
ABCT 2024 58th Annual Convention Main banner
Psychology Tools Ad
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded Session
Recorded Session
Ticketed Session
Ticketed Session
Back
Evaluation ViewAttendees 3

Suicide and Self-Injury
Symposia

Symposium 105 - Reducing Suicide Reattempts in Hospitalized Patients: The Institute of Living Suicide Prevention Project

Saturday, November 16, 2024
4:30 PM – 6:00 PM EST
Location: Grand Ballroom K/L, Level 5, Downtown Marriott
CE: 1.5

Keywords: Suicide, ,
Level of Familiarity: Moderate
Recommended Readings: Diefenbach, G. J., Rudd, M. D., Merling, L. F., Davies, C., Katz, B., & Tolin, D. F. (2021). Brief cognitive-behavioral therapy for suicidal inpatients. Cognitive and Behavioral Practice, 28, 224-240.,   Rudd, M. D., Joiner, T. E., & Rajab, M. H. (2001). Treating suicidal behavior: An effective, time-limited approach. Guilford Press.,   Rudd, M. D., Bryan, C. J., Wertenberger, E. G., Peterson, A. L., Young-McCaughan, S., Mintz, J., Williams, S. R., Arne, K. A., Breitbach, J., Delano, K., Wilkinson, E., & Bruce, T. O. (2015). Brief cognitive-behavioral therapy effects on post-treatment suicide attempts in a military sample: results of a randomized clinical trial with 2-year follow-up. American Journal of Psychiatry, 172(5), 441-449. https://doi.org/10.1176/appi.ajp.2014.14070843,   ,  

In 2022, suicide rates reached an estimated all-time high, with nearly 50,000 Americans dying by suicide (Centers for Disease Control and Prevention, 2023). While suicidal crisis is a common reason for inpatient admissions, risk of death by suicide is particularly elevated within the first 3 months of discharge among patients admitted for suicidal ideation or behavior (Chung et al., 2017) Thus, effectively assessing, conceptualizing, and treating these patients is critical.
Though outpatient cognitive-behavioral therapy (CBT) is efficacious for suicide prevention, existing studies of suicide prevention in inpatient settings are small and have not yielded significant effects for reducing post-discharge suicide behaviors (Yiu et al., 2021)
The Institute of Living (IOL) in Hartford, CT recently undertook the largest trial to date of inpatient CBT for suicide prevention. The aim of this program was to improve assessment and case formulation of patients admitted to the hospital following a suicide attempt, to refine existing CBT protocols for a short-stay inpatient setting, and to determine the efficacy of inpatient CBT for reducing suicidal behavior over a 6-month follow up period.
The present symposium will describe an array of results from the IOL suicide prevention program. Dr. Gretchen Diefenbach will present the results of a randomized controlled trial of brief CBT for inpatients (BCBT-I). Ms. Andrea Perez-Munoz will discuss the predictive capacity of assessing wishes to live and to die, and the utility of these questions for predicting suicide reattempts over the follow-up period. Dr. Jessica Stubbing will present qualitative and quantitative data on suicidal ideation and behavior in patients from sexual and gender minority backgrounds, and how sexual and gender identity is and could be incorporated into treatment. Dr. Kayla Lord will discuss the ability of the Death-Implicit Association Test (D-IAT) to predict suicide reattempts over the follow-up period. Our discussant, Dr. David Rudd, will summarize the highlights of the presentations, discuss how these presentations fit within a larger framework, and suggest directions for future research.

Learning Objectives:

At the end of this session, the learner will be able to:
  1. Describe the efficacy of brief CBT for patients hospitalized following a suicide attempt at reducing the risk of reattempt.
  2. Discuss the predictive utility of asking suicidal inpatients about wishes to live and wishes to die.
  3. Discuss the experience of suicidality and suicide treatment among patients from sexual and gender minoritized backgrounds.
  4. Describe the predictive utility of the Death-Implicit Association Test among patients hospitalized following a suicide attempt.
  5. Describe the adaptation of suicide-related CBT for inpatient populations.

Presentations:

  • 4:30 PM – 6:00 PM EST
    (SYM 105) Brief Cognitive-behavioral Therapy for Suicidal Inpatients: A Randomized Clinical Trial

    Speaker: Gretchen J. Diefenbach, Ph.D. (she/her/hers) – Institute of Living

    Co-author: Kayla A. Lord, Ph.D. (she/her/hers) – Anxiety Disorders Center, The Institute of Living

    Co-author: Jessica Stubbing, Other (she/her/hers) – The University of Auckland

    Co-author: Michael David Rudd, ABPP, Ph.D. – University of Memphis

    Co-author: Hannah Levy, Ph.D. (she/her/hers) – Anxiety Disorders Center, The Institute of Living

    Co-author: Blaise Worden, Ph.D. – Institute of Living

    Co-author: Kimberly S. Sain, Ph.D. (she/her/hers) – Anxiety Disorders Center, The Institute of Living

    Co-author: Jessica Bimstein, B.A. – University of Pennsylvania

    Co-author: Tyler B. Rice, B.S. (she/her/hers) – Florida State University

    Co-author: Kate Everhardt, B.S. – San Jose State University

    Co-author: Ralitza Gueorguieva, Ph.D. – Yale University

    Co-author: David Tolin, ABPP, Ph.D. (he/him/his) – Anxiety Disorders Center, The Institute of Living

  • 4:30 PM – 6:00 PM EST
    SYM (105) Predictive Validity and Treatment Sensitivity of the Death-implicit Association Test in a Sample of Suicidal Inpatients

    Speaker: Kayla A. Lord, Ph.D. (she/her/hers) – Anxiety Disorders Center, The Institute of Living

    Co-author: Hannah Levy, Ph.D. (she/her/hers) – Anxiety Disorders Center, The Institute of Living

    Co-author: Tyler B. Rice, B.S. (she/her/hers) – Florida State University

    Co-author: Kimberly S. Sain, Ph.D. (she/her/hers) – Anxiety Disorders Center, The Institute of Living

    Co-author: Jessica Stubbing, Other (she/her/hers) – The University of Auckland

    Co-author: Gretchen J. Diefenbach, Ph.D. (she/her/hers) – Institute of Living

    Co-author: David Tolin, ABPP, Ph.D. (he/him/his) – Anxiety Disorders Center, The Institute of Living

  • 4:30 PM – 6:00 PM EST
    SYM (105) Suicide Ambivalence: Resolved Wish to Die as a Clinical Marker of High Risk

    Speaker: Andrea Perez-Munoz, M.S. (she/her/hers) – University of Memphis

    Co-author: Gretchen J. Diefenbach, Ph.D. (she/her/hers) – Institute of Living

    Co-author: David Tolin, ABPP, Ph.D. (he/him/his) – Anxiety Disorders Center, The Institute of Living

    Co-author: Michael David Rudd, ABPP, Ph.D. – University of Memphis

  • 4:30 PM – 6:00 PM EST
    SYM (105) Suicide Prevention for Gender Diverse People: Exploring the Integration of Minority Stress into BCBT-I

    Speaker: Jessica Stubbing, Other (she/her/hers) – The University of Auckland

    Co-author: Kate Everhardt, B.S. – San Jose State University

    Co-author: Tyler B. Rice, B.S. (she/her/hers) – Florida State University

    Co-author: Laura Saunders, ABPP, Psy.D. – Institute of Living

    Co-author: David Tolin, ABPP, Ph.D. (he/him/his) – Anxiety Disorders Center, The Institute of Living

    Co-author: Michael David Rudd, ABPP, Ph.D. – University of Memphis

    Co-author: Gretchen J. Diefenbach, Ph.D. (she/her/hers) – Institute of Living

Back to Top